La. Cameron et al., EXPRESSION OF IL-4, C-EPSILON RNA, AND I-EPSILON RNA IN THE NASAL-MUCOSA OF PATIENTS WITH SEASONAL RHINITIS - EFFECT OF TOPICAL CORTICOSTEROIDS, Journal of allergy and clinical immunology, 101(3), 1998, pp. 330-336
Background: Nasal allergen provocation has demonstrated that allergen-
induced rhinitis is associated with an increase in local IL-4 mRNA and
IgE heavy chain (C epsilon) and IgE heavy chain promoter (I epsilon)
RNA and that pretreatment with topical glucocorticosteroids inhibits t
he increase in these transcripts. Objective; This study was undertaken
ta determine whether observations made after acute allergen provocati
on can be extended to the case of chronic exposure experienced during
the pollen season. Methods: Biopsy specimens were obtained from the in
ferior turbinate of 33 pollen-sensitive subjects with allergic rhiniti
s before and during pollen season. Patients were randomized in a doubl
e-blind fashion and treated with either topical steroids (200 mu g flu
ticasone propionate twice daily; n = 16) or matched placebo nasal spra
g (n = 17) before the pollen season. Alkaline phospatase anti-alkaline
phosphatase immunocytochemistry was used to identify B cells (CD20(+)
), and in situ hybridization was used to detect IL-4, C epsilon and I
epsilon RNA(+) cells. Results: Baseline examination revealed IL-4 and
C epsilon RNA but virtually no I epsilon RNA(+) cells in the nasal muc
osa. Analysis revealed a significant difference in the expression of C
epsilon and I epsilon RNA(+) cells (p < 0.001). Biopsy specimens take
n after antigen exposure exhibited highly significant increases in pla
cebo-treated (p < 0.001) but not steroid-treated patients. In both gro
ups, the number of CD20(+) cells was unchanged when preexposure and po
stexposure biopsy specimens were compared. Conclusions: These results
show strong support for the hypothesis that IgE class switching occurs
locally within the nasal mucosa of subjects with seasonal allergic rh
initis and that this response can be inhibited through strategies dire
cted against local IgE production.